Neurology & Cognitive Research

Advancing Alzheimer’s Clinical Research

Alzheimer’s disease affects millions of individuals and families worldwide, creating an urgent need for innovative therapies and early intervention strategies. CenExel partners with sponsors to support cutting-edge Alzheimer’s clinical trials focused on memory loss, cognitive decline, and neurodegenerative conditions across diverse participant populations.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Leading Alzheimer’s Clinical Research

CenExel provides specialized expertise in Alzheimer’s and neurodegenerative clinical trials, combining scientific leadership with experienced operational teams. Our sites support early-phase through late-stage studies focused on cognitive disorders, dementia care, biomarker analysis, and participant-centered research solutions.

Advance Cognitive Care

Our research teams help improve treatment approaches for memory-related and neurodegenerative disorders.

Accelerate Trial Success

Efficient enrollment strategies and experienced investigators help sponsors move studies forward faster.
Conditions Covered

Alzheimer’s & Cognitive Conditions We Research

Our Alzheimer’s research sites support a broad range of neurodegenerative and cognitive disorders across adult and aging populations.

  • Alzheimer’s Disease
  • Mild Cognitive Impairment (MCI)
  • Dementia
  • Early-Onset Alzheimer’s
  • Memory Loss Disorders
  • Parkinson’s Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
Our Approach

Why Sponsors Choose CenExel for Alzheimer’s Research

Our Alzheimer’s research network combines neurology expertise, advanced diagnostics, and participant-focused recruitment strategies to support successful clinical outcomes.

01

Specialized Neurology Teams

Experienced investigators and coordinators focused on cognitive and neurodegenerative disorders.

02

Biomarker & Imaging Support

Support for MRI, PET imaging, and biomarker-driven Alzheimer’s studies.

03

Diverse Patient Recruitment

Access to broad and aging patient populations across multiple U.S. locations.

04

Efficient Enrollment Performance

Optimized recruitment and retention strategies for Alzheimer’s clinical trials.

Phase Coverage

Supported Alzheimer’s Trial Phases

CenExel supports early and late-stage Alzheimer’s clinical trials — from first-in-human studies through Phase IV post-market research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our experienced neurology research teams support biomarker validation, cognitive testing, imaging studies, and long-term Alzheimer’s disease management trials.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog